Actively Recruiting
Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2025-03-10
3375
Participants Needed
4
Research Sites
360 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
CONDITIONS
Official Title
Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have chronic kidney disease stage 4 or higher
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
AIDER - Unité de Dialyse d'Alès
Alès, France, 30100
Actively Recruiting
2
AIDER - Unité de Dialyse de Nîmes, CHU Carémeau
Nîmes, France, 30029
Not Yet Recruiting
3
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France, 30029
Not Yet Recruiting
4
Gardialyse
Nîmes, France, 30900
Not Yet Recruiting
Research Team
O
Olivier Moranne, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here